Search - tctmd.com

Displaying 41 - 60 of 102

Sort: Relevancy | Date

News Daily News

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

Todd Neale

September 12, 2023

News Daily News

Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts

Michael O'Riordan

September 08, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Michael O'Riordan

July 11, 2023

News Conference News ADA 2023

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

L.A. McKeown

June 28, 2023

News Daily News

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Michael O'Riordan

April 11, 2023

News Daily News

Mediterranean Diet’s CV Benefits Extend to Women: Meta-analysis

Caitlin E. Cox

March 15, 2023

News Daily News

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Michael O'Riordan

February 16, 2023

News Daily News

Food Insecurity May Drive Heart Failure, CAD Risks in Black Individuals

L.A. McKeown

February 06, 2023

News Daily News

AHA Annual Statistics Show COVID’s Disruptive Impact

L.A. McKeown

January 30, 2023

News Daily News

Total Meals, Not Timing, Drives Long-term Body Weight Changes

Todd Neale

January 24, 2023

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Opinion CV Team Dispatch

October 2022 News Roundup

L.A. McKeown

October 01, 2022

News Daily News

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

Shelley Wood

August 23, 2022

News Daily News

Intermittent Fasting Trial Comes Out (Partly) Positive, but CV Impact Mixed

Todd Neale

August 12, 2022

News Daily News

Cardiorespiratory Fitness Is Key to Longevity, Regardless of Age, Sex, and Race

Yael L. Maxwell

August 09, 2022

News Daily News

Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained

Yael L. Maxwell

July 15, 2022

News Daily News

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Michael O'Riordan

July 05, 2022

News Daily News

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

L.A. McKeown

June 09, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

Advertisement

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Mediterranean Diet’s CV Benefits Extend to Women: Meta-analysis

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Food Insecurity May Drive Heart Failure, CAD Risks in Black Individuals

AHA Annual Statistics Show COVID’s Disruptive Impact

Total Meals, Not Timing, Drives Long-term Body Weight Changes

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

October 2022 News Roundup

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

Intermittent Fasting Trial Comes Out (Partly) Positive, but CV Impact Mixed

Cardiorespiratory Fitness Is Key to Longevity, Regardless of Age, Sex, and Race

Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content